Fitch Assigns ‘BBB-’ Rating To Airtel’s Proposed $1 Billion FCCB; Puts It On Negative Rating Watch
Whistle Blower Mail Hits Hard: Sun Pharma Shares Dip 11 Per Cent As SEBI Reopens Insider Trading Case
